Cargando…

Lipotoxicity and Decreased Islet Graft Survival

OBJECTIVE: To evaluate if baseline serum lipids are associated with islet graft survival in type 1 diabetes islet transplant (ITx) recipients. RESEARCH DESIGN AND METHODS: Baseline fasting lipid profile was collected from 44 ITx recipients. Comparisons were performed between subjects below and above...

Descripción completa

Detalles Bibliográficos
Autores principales: Leitão, Cristiane B., Bernetti, Karina, Tharavanij, Thipaporn, Cure, Pablo, Lauriola, Vincenzo, Berggren, Per-Olof, Ricordi, Camillo, Alejandro, Rodolfo
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827526/
https://www.ncbi.nlm.nih.gov/pubmed/20009097
http://dx.doi.org/10.2337/dc09-1387
_version_ 1782177958082904064
author Leitão, Cristiane B.
Bernetti, Karina
Tharavanij, Thipaporn
Cure, Pablo
Lauriola, Vincenzo
Berggren, Per-Olof
Ricordi, Camillo
Alejandro, Rodolfo
author_facet Leitão, Cristiane B.
Bernetti, Karina
Tharavanij, Thipaporn
Cure, Pablo
Lauriola, Vincenzo
Berggren, Per-Olof
Ricordi, Camillo
Alejandro, Rodolfo
author_sort Leitão, Cristiane B.
collection PubMed
description OBJECTIVE: To evaluate if baseline serum lipids are associated with islet graft survival in type 1 diabetes islet transplant (ITx) recipients. RESEARCH DESIGN AND METHODS: Baseline fasting lipid profile was collected from 44 ITx recipients. Comparisons were performed between subjects below and above the median values of each lipid fraction. Differences in outcomes were compared by Kaplan-Meier curves and Cox regression analysis. RESULTS: Subjects with baseline fasting plasma triglycerides and VLDL cholesterol above the median had shorter islet graft survival (triglycerides: 39.7 ± 6.1 vs. 61.3 ± 6.6 months, P = 0.029, and VLDL: 41.5 ± 5.7 vs. 62.8 ± 7.3 months, P = 0.032). Total, LDL, and HDL cholesterol did not influence islet function. Triglycerides (odds ratio 2.97 [95% CI 1.03–8.52], P = 0.044) maintained its association with graft failure after adjustments for confounders. CONCLUSIONS: Higher baseline triglycerides are associated with earlier decline in islet graft function. Prospective clinical trials should address whether it is directly caused by lipotoxicity and if strategies focusing on lowering serum lipids may prolong islet graft survival.
format Text
id pubmed-2827526
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-28275262011-03-01 Lipotoxicity and Decreased Islet Graft Survival Leitão, Cristiane B. Bernetti, Karina Tharavanij, Thipaporn Cure, Pablo Lauriola, Vincenzo Berggren, Per-Olof Ricordi, Camillo Alejandro, Rodolfo Diabetes Care Original Research OBJECTIVE: To evaluate if baseline serum lipids are associated with islet graft survival in type 1 diabetes islet transplant (ITx) recipients. RESEARCH DESIGN AND METHODS: Baseline fasting lipid profile was collected from 44 ITx recipients. Comparisons were performed between subjects below and above the median values of each lipid fraction. Differences in outcomes were compared by Kaplan-Meier curves and Cox regression analysis. RESULTS: Subjects with baseline fasting plasma triglycerides and VLDL cholesterol above the median had shorter islet graft survival (triglycerides: 39.7 ± 6.1 vs. 61.3 ± 6.6 months, P = 0.029, and VLDL: 41.5 ± 5.7 vs. 62.8 ± 7.3 months, P = 0.032). Total, LDL, and HDL cholesterol did not influence islet function. Triglycerides (odds ratio 2.97 [95% CI 1.03–8.52], P = 0.044) maintained its association with graft failure after adjustments for confounders. CONCLUSIONS: Higher baseline triglycerides are associated with earlier decline in islet graft function. Prospective clinical trials should address whether it is directly caused by lipotoxicity and if strategies focusing on lowering serum lipids may prolong islet graft survival. American Diabetes Association 2010-03 2009-12-15 /pmc/articles/PMC2827526/ /pubmed/20009097 http://dx.doi.org/10.2337/dc09-1387 Text en © 2010 by the American Diabetes Association. https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) for details.
spellingShingle Original Research
Leitão, Cristiane B.
Bernetti, Karina
Tharavanij, Thipaporn
Cure, Pablo
Lauriola, Vincenzo
Berggren, Per-Olof
Ricordi, Camillo
Alejandro, Rodolfo
Lipotoxicity and Decreased Islet Graft Survival
title Lipotoxicity and Decreased Islet Graft Survival
title_full Lipotoxicity and Decreased Islet Graft Survival
title_fullStr Lipotoxicity and Decreased Islet Graft Survival
title_full_unstemmed Lipotoxicity and Decreased Islet Graft Survival
title_short Lipotoxicity and Decreased Islet Graft Survival
title_sort lipotoxicity and decreased islet graft survival
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827526/
https://www.ncbi.nlm.nih.gov/pubmed/20009097
http://dx.doi.org/10.2337/dc09-1387
work_keys_str_mv AT leitaocristianeb lipotoxicityanddecreasedisletgraftsurvival
AT bernettikarina lipotoxicityanddecreasedisletgraftsurvival
AT tharavanijthipaporn lipotoxicityanddecreasedisletgraftsurvival
AT curepablo lipotoxicityanddecreasedisletgraftsurvival
AT lauriolavincenzo lipotoxicityanddecreasedisletgraftsurvival
AT berggrenperolof lipotoxicityanddecreasedisletgraftsurvival
AT ricordicamillo lipotoxicityanddecreasedisletgraftsurvival
AT alejandrorodolfo lipotoxicityanddecreasedisletgraftsurvival